IL118003A0 - Novel vip fragments and pharmaceutical compositions comprising them - Google Patents

Novel vip fragments and pharmaceutical compositions comprising them

Info

Publication number
IL118003A0
IL118003A0 IL11800396A IL11800396A IL118003A0 IL 118003 A0 IL118003 A0 IL 118003A0 IL 11800396 A IL11800396 A IL 11800396A IL 11800396 A IL11800396 A IL 11800396A IL 118003 A0 IL118003 A0 IL 118003A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
vip fragments
novel
novel vip
fragments
Prior art date
Application number
IL11800396A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Ramot University Authority For A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Ramot University Authority For A filed Critical Yeda Res & Dev
Priority to IL11800396A priority Critical patent/IL118003A0/xx
Publication of IL118003A0 publication Critical patent/IL118003A0/xx
Priority to IL12662297A priority patent/IL126622A/xx
Priority to AU25753/97A priority patent/AU715036B2/en
Priority to JP09537899A priority patent/JP2001502294A/ja
Priority to CA002252458A priority patent/CA2252458A1/fr
Priority to EP97917393A priority patent/EP0904294A1/fr
Priority to US09/171,654 priority patent/US6239107B1/en
Priority to PCT/IL1997/000129 priority patent/WO1997040070A1/fr
Priority to CNB971949700A priority patent/CN1191272C/zh
Priority to KR1019980708505A priority patent/KR100493830B1/ko
Priority to TW086107759A priority patent/TW487711B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL11800396A 1996-04-23 1996-04-23 Novel vip fragments and pharmaceutical compositions comprising them IL118003A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IL11800396A IL118003A0 (en) 1996-04-23 1996-04-23 Novel vip fragments and pharmaceutical compositions comprising them
KR1019980708505A KR100493830B1 (ko) 1996-04-23 1997-04-18 친지성부및혈관작용성장펩티드(vip)의프래그먼트의콘쥬게이트
CA002252458A CA2252458A1 (fr) 1996-04-23 1997-04-18 Conjugues de fractions lypophiles et de fragments de peptide intestinal vasoactif (vip)
AU25753/97A AU715036B2 (en) 1996-04-23 1997-04-18 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
JP09537899A JP2001502294A (ja) 1996-04-23 1997-04-18 親油性分子と血管作用性小腸ペプチド（ｖｉｐ）の断片との結合体
IL12662297A IL126622A (en) 1996-04-23 1997-04-18 Conjugates of lipophilic moieties and fragments of vasoactive intestinal petide vip
EP97917393A EP0904294A1 (fr) 1996-04-23 1997-04-18 Conjugues de fractions lypophiles et de fragments de peptide intestinal vasoactif (vip)
US09/171,654 US6239107B1 (en) 1996-04-23 1997-04-18 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
PCT/IL1997/000129 WO1997040070A1 (fr) 1996-04-23 1997-04-18 Conjugues de fractions lypophiles et de fragments de peptide intestinal vasoactif (vip)
CNB971949700A CN1191272C (zh) 1996-04-23 1997-04-18 亲脂组分和血管活性肠肽片段的缀合物
TW086107759A TW487711B (en) 1996-04-23 1997-06-05 Conjugates of lipophilic moieties and peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11800396A IL118003A0 (en) 1996-04-23 1996-04-23 Novel vip fragments and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
IL118003A0 true IL118003A0 (en) 1996-08-04

Family

ID=11068793

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11800396A IL118003A0 (en) 1996-04-23 1996-04-23 Novel vip fragments and pharmaceutical compositions comprising them

Country Status (10)

Country Link
US (1) US6239107B1 (fr)
EP (1) EP0904294A1 (fr)
JP (1) JP2001502294A (fr)
KR (1) KR100493830B1 (fr)
CN (1) CN1191272C (fr)
AU (1) AU715036B2 (fr)
CA (1) CA2252458A1 (fr)
IL (1) IL118003A0 (fr)
TW (1) TW487711B (fr)
WO (1) WO1997040070A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099003A1 (en) * 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US6713445B1 (en) * 1998-04-06 2004-03-30 Advanced Immuni T, Inc. Peptides for treatment of HIV infection
IL125908A (en) * 1998-08-24 2005-05-17 Nst Neurosurvival Technologies Peptides and pharmaceutical compositions comprising same
IL131266A0 (en) 1999-08-05 2001-01-28 N S T Neurosurvival Technologi Peptides and pharmaceutical compositions comprising same
EP1126871A2 (fr) * 1998-10-16 2001-08-29 The Government of The United States of America, as represented by The Department of Health and Human Services Therapie combinee avec antagoniste du polypeptide vasoactif intestinal
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
PT2319928E (pt) 1998-10-23 2013-06-28 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
KR100345214B1 (ko) * 1999-08-17 2002-07-25 이강춘 생체적합성 고분자가 수식된 펩타이드의 비점막 전달
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
ATE307144T1 (de) * 2000-05-22 2005-11-15 Univ Ramot Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauen
US20030113270A1 (en) * 2001-12-14 2003-06-19 Clark Abbot F. Vasoactive intestinal peptides for glaucomatous retinopathy
CA2490409A1 (fr) 2002-06-28 2004-01-08 Centocor, Inc. Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
US7314859B2 (en) * 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
EP2664672A1 (fr) * 2003-04-17 2013-11-20 Alnylam Pharmaceuticals Inc. Agents iARN modifiés
US8017762B2 (en) * 2003-04-17 2011-09-13 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US7851615B2 (en) * 2003-04-17 2010-12-14 Alnylam Pharmaceuticals, Inc. Lipophilic conjugated iRNA agents
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US7723509B2 (en) 2003-04-17 2010-05-25 Alnylam Pharmaceuticals IRNA agents with biocleavable tethers
WO2006010057A2 (fr) 2004-07-08 2006-01-26 Amgen Inc. Peptides therapeutiques
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
JP5718058B2 (ja) * 2008-02-08 2015-05-13 キューピーエス リミテッド ライアビリティ カンパニー タンパク質又はペプチドの徐放送達用組成物
MX2010013436A (es) 2008-06-09 2011-06-21 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de disfuncion sexual.
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2011063366A1 (fr) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Peptides cycliques spécifiques du récepteur de la mélanocortine-1
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
US9694051B2 (en) 2011-04-07 2017-07-04 The Board Of Trustees Of The Leland Stanford Junior University Long-acting peptide analogs
CN116063580A (zh) 2016-01-04 2023-05-05 艾得佩索拉公司 肽类似物
WO2017139154A1 (fr) 2016-02-09 2017-08-17 Adepthera Llc Dosage et utilisation d'agonistes de clr/ramp à action durable
WO2019005623A1 (fr) 2017-06-30 2019-01-03 Adepthera Llc Analogues peptidiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
AU6446190A (en) * 1989-09-15 1991-04-18 Rutgers, The State University Of New Jersey Process for inducing analgesia, peptides and therapeutic compositions
DK0463450T3 (da) * 1990-06-26 1994-06-27 Sanwa Kagaku Kenkyusho Co Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them
US5972883A (en) * 1993-03-16 1999-10-26 Yeda Research And Development Co. Ltd. Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Also Published As

Publication number Publication date
AU2575397A (en) 1997-11-12
CA2252458A1 (fr) 1997-10-30
CN1191272C (zh) 2005-03-02
AU715036B2 (en) 2000-01-13
US6239107B1 (en) 2001-05-29
WO1997040070A1 (fr) 1997-10-30
CN1219938A (zh) 1999-06-16
KR100493830B1 (ko) 2006-04-21
TW487711B (en) 2002-05-21
JP2001502294A (ja) 2001-02-20
KR20000010614A (ko) 2000-02-25
EP0904294A1 (fr) 1999-03-31

Similar Documents

Publication Publication Date Title
IL118003A0 (en) Novel vip fragments and pharmaceutical compositions comprising them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
AP9901495A0 (en) Aqueous-based pharmaceutical composition
EG24118A (en) Pharmaceutical compositions
EP0943327A4 (fr) Compositions medicinales
ZA9710006B (en) Novel pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
GB9610359D0 (en) Pharmaceutical compositions
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA979726B (en) Pharmaceutical compositions
HUP9601756A3 (en) New anticoagulant glycosides and pharmaceutical compositions containing them
IL105061A0 (en) Pharmaceutical compositions comprising vip,or analogues,derivatives and fragments thereof
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them
GB9620592D0 (en) Pharmaceutical compositions and their use
IL117478A0 (en) Compositions comprising iron-chelates and their manufacture
IL137915A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
ZA962792B (en) Pharmaceutical composition
GB9626185D0 (en) Pharmaceutical composition